Concepedia

John Bosco Ruganzu

JB

Statistics

Publications

10

Citations

643

H-Index

10

Active since

2019

Affiliations

Xi'an Jiaotong University(Current)

First Affiliated Hospital of Xi'an Jiaotong University

Second Affiliated Hospital of Xi'an Jiaotong University

John Bosco Ruganzu is an author at Xi'an Jiaotong University specializing in neuroscience, life sciences, and neurodegenerative disorders.

ORCID

Publications per year

2019–2025

10

Publications

10

Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro

Bo Ding, Chengheng Lin, Qian Liu et al. · Journal of Neuroinflammation · 2020 · 199 citations · Full text

, , +17

TREM2 overexpression rescues cognitive deficits in APP/PS1 transgenic mice by reducing neuroinflammation via the JAK/STAT/SOCS signaling pathway

John Bosco Ruganzu, Quzhao Zheng, Xiangyuan Wu et al. · Experimental Neurology · 2020 · 114 citations

, , +14

TREM2 Inhibits Tau Hyperphosphorylation and Neuronal Apoptosis via the PI3K/Akt/GSK-3β Signaling Pathway In vivo and In vitro

Xiaoqian Peng, Hongsong Guo, Xiao Zhang et al. · Molecular Neurobiology · 2023 · 66 citations

, , +16

Downregulation of TREM2 expression exacerbates neuroinflammatory responses through TLR4-mediated MAPK signaling pathway in a transgenic mouse model of Alzheimer’s disease

John Bosco Ruganzu, Xiaoqian Peng, Yingying He et al. · Molecular Immunology · 2021 · 55 citations

, , +17

Tanshinone IIA ameliorates cognitive deficits by inhibiting endoplasmic reticulum stress-induced apoptosis in APP/PS1 transgenic mice

Yingying He, John Bosco Ruganzu, Chengheng Lin et al. · Neurochemistry International · 2019 · 54 citations

, , +16

1–5 of 10